Interim estimates in null models of COVID-19 vaccine effectiveness

Recently released interim numbers from advanced vaccine candidate clinical trials suggest that a COVID-19 vaccine effectiveness (VE) of >90% is achievable. However, SARS-CoV-2 transmission dynamics are highly heterogeneous and exhibit localized bursts of transmission, which may lead to sharp loca...

Descripción completa

Detalles Bibliográficos
Autor principal: Lisewski, Andreas Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970752/
https://www.ncbi.nlm.nih.gov/pubmed/33746095
http://dx.doi.org/10.1016/j.ijid.2021.03.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970752/
https://www.ncbi.nlm.nih.gov/pubmed/33746095
http://dx.doi.org/10.1016/j.ijid.2021.03.050

Ejemplares similares